Search

Roche Holding AG

Затворен

СекторЗдравеопазване

278.6 -0.14

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

273.4

Максимум

280

Ключови измерители

By Trading Economics

Приходи

6.3B

Продажби

31B

P/E

Средно за сектора

26.169

57.333

Дивидентна доходност

3.6

Марж на печалбата

20.347

Служители

103,249

EBITDA

11B

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.60%

2.63%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

205B

Предишно отваряне

278.74

Предишно затваряне

278.6

Roche Holding AG Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.04.2025 г., 07:30 ч. UTC

Печалби

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24.04.2025 г., 05:31 ч. UTC

Печалби

Roche Sales Rise Boosted By Key Drugs

9.04.2025 г., 09:39 ч. UTC

Значими двигатели на пазара

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12.03.2025 г., 09:23 ч. UTC

Значими двигатели на пазара

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30.01.2025 г., 09:36 ч. UTC

Печалби

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30.01.2025 г., 06:32 ч. UTC

Печалби

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

24.04.2025 г., 09:39 ч. UTC

Пазарно говорене
Печалби

Roche's Pipeline in Focus After Solid Results -- Market Talk

24.04.2025 г., 09:24 ч. UTC

Пазарно говорене
Печалби

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24.04.2025 г., 09:18 ч. UTC

Пазарно говорене
Печалби

Roche's Results Are Solid -- Market Talk

24.04.2025 г., 05:16 ч. UTC

Топ новини

Roche Sales Rise, Boosted By Key Drugs

22.04.2025 г., 10:51 ч. UTC

Топ новини

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15.04.2025 г., 09:55 ч. UTC

Пазарно говорене

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9.04.2025 г., 10:03 ч. UTC

Пазарно говорене
Печалби

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9.04.2025 г., 07:23 ч. UTC

Пазарно говорене

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3.04.2025 г., 08:41 ч. UTC

Пазарно говорене

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3.04.2025 г., 07:51 ч. UTC

Пазарно говорене

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31.03.2025 г., 09:31 ч. UTC

Горещи акции

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13.03.2025 г., 07:46 ч. UTC

Пазарно говорене

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12.03.2025 г., 16:34 ч. UTC

Топ новини

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12.03.2025 г., 08:51 ч. UTC

Пазарно говорене

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12.03.2025 г., 08:18 ч. UTC

Пазарно говорене

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13.02.2025 г., 11:43 ч. UTC

Пазарно говорене

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30.01.2025 г., 07:56 ч. UTC

Пазарно говорене
Печалби

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30.01.2025 г., 06:04 ч. UTC

Печалби

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30.01.2025 г., 06:04 ч. UTC

Печалби

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30.01.2025 г., 06:04 ч. UTC

Печалби

Roche Issues 2025 View

30.01.2025 г., 06:03 ч. UTC

Печалби

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30.01.2025 г., 06:03 ч. UTC

Печалби

Roche 2024 Core Operating Profit CHF20.82B

30.01.2025 г., 06:03 ч. UTC

Печалби

Roche 2024 Net Pft CHF9.19B

30.01.2025 г., 06:02 ч. UTC

Печалби

Analysts Saw 2024 Core EPS at CHF18.59

Roche Holding AG Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.